{
    "Trade/Device Name(s)": [
        "Dimension TNI Flex reagent cartridge",
        "CTNI Sample Diluent"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K081643",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063756",
        "K053577"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MMI"
    ],
    "Summary Letter Date": "June 11, 2008",
    "Summary Letter Received Date": "June 12, 2008",
    "Submission Date": "June 3, 2008",
    "Regulation Number(s)": [
        "21CFR862.1215"
    ],
    "Regulation Name(s)": [
        "Creatine Phosphokinase/Creatine Kinase or Isoenzymes Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "cardiac"
    ],
    "Analyte(s)": [
        "Cardiac troponin I"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dimension EXLTM integrated chemistry system with LOCI module",
        "Dimension Vista analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay",
        "LOCI technology"
    ],
    "Methodologies": [
        "Homogeneous sandwich immunoassay"
    ],
    "Submission Type(s)": [
        "Reagent cartridge",
        "Diluent"
    ],
    "Document Summary": "FDA 510(k) summary for Dimension TNI Flex reagent cartridge and CTNI Sample Diluent for quantitative measurement of cardiac troponin I using chemiluminescent immunoassay on Dimension EXLTM system.",
    "Indications for Use Summary": "For quantitative measurement of cardiac troponin I in human serum and plasma to aid in the diagnosis of acute myocardial infarction and risk stratification in acute coronary syndromes; CTNI Sample Diluent for manual dilution of samples with elevated cardiac troponin I results.",
    "fda_folder": "Clinical Chemistry"
}